Expression Levels of the ABCG2 Multidrug Transporter in Human Erythrocytes Correspond to Pharmacologically Relevant Genetic Variations

ABCG2 null alleles define the Jr(a−) blood group phenotype

(2012) Teresa Zelinski et al.   NATURE GENETICS

Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior

(2012) Carole Saison et al.   NATURE GENETICS

Decreased extra-renal urate excretion is a common cause of hyperuricemia

(2012) Kimiyoshi Ichida et al.   Nature Communications

The Challenge of Exploiting ABCG2 in the Clinic

(2011) Robert W. Robey et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Ubiquitin-Mediated Proteasomal Degradation of ABC Transporters: a New Aspect of Genetic Polymorphisms and Clinical Impacts

(2011) Hiroshi Nakagawa et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Multiple Genetic Loci Influence Serum Urate Levels and Their Relationship With Gout and Cardiovascular Disease Risk Factors

(2010) Qiong Yang et al.   Circulation-Cardiovascular Genetics

Proteomic mining of the red blood cell: focus on the membrane proteome

(2010) Bruno M Alexandre   Expert Review of Proteomics

LC−MS/MS Mediated Absolute Quantification and Comparison of Bile Salt Export Pump and Breast Cancer Resistance Protein in Livers and Hepatocytes across Species

(2009) Na Li et al.   ANALYTICAL CHEMISTRY

ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis

(2009) S. Cotte et al.   BRAIN

Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties

(2009) C Hegedűs et al.   BRITISH JOURNAL OF PHARMACOLOGY

Impact of functional ABCG2 polymorphisms on the adverse effects of gefitinib in Japanese patients with non–small-cell lung cancer

(2009) Keiichi Akasaka et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Red blood cell (RBC) membrane proteomics — Part I: Proteomics and RBC physiology

(2009) Erica M. Pasini et al.   Journal of Proteomics

Pharmacogenetics of Membrane Transporters: An Update on Current Approaches

(2009) Tristan M. Sissung et al.   MOLECULAR BIOTECHNOLOGY

Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population

(2009) H. Matsuo et al.   Science Translational Medicine

The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME–Tox)

(2008) Gergely Szakács et al.   DRUG DISCOVERY TODAY

Interaction with the 5D3 Monoclonal Antibody Is Regulated by Intramolecular Rearrangements but Not by Covalent Dimer Formation of the Human ABCG2 Multidrug Transporter

(2008) Csilla Özvegy-Laczka et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Genetic Variation in Efflux Transporters Influences Outcome to Methotrexate Therapy in Patients with Psoriasis

(2008) Richard B. Warren et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Major SNP (Q141K) Variant of Human ABC Transporter ABCG2 Undergoes Lysosomal and Proteasomal Degradations

(2008) Tomoka Furukawa et al.   PHARMACEUTICAL RESEARCH

Pharmacogenomic importance of ABCG2

(2008) George Cusatis et al.   PHARMACOGENOMICS